Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |